[go: up one dir, main page]

AR203747A1 - PROCEDURE TO OBTAIN ARGININE PYROGLUTAMATE - Google Patents

PROCEDURE TO OBTAIN ARGININE PYROGLUTAMATE

Info

Publication number
AR203747A1
AR203747A1 AR253103A AR25310374A AR203747A1 AR 203747 A1 AR203747 A1 AR 203747A1 AR 253103 A AR253103 A AR 253103A AR 25310374 A AR25310374 A AR 25310374A AR 203747 A1 AR203747 A1 AR 203747A1
Authority
AR
Argentina
Prior art keywords
procedure
obtain arginine
arginine pyroglutamate
pyroglutamate
arginine
Prior art date
Application number
AR253103A
Other languages
Spanish (es)
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Application granted granted Critical
Publication of AR203747A1 publication Critical patent/AR203747A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR253103A 1973-04-04 1974-04-02 PROCEDURE TO OBTAIN ARGININE PYROGLUTAMATE AR203747A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49236/73A IT1019020B (en) 1973-04-04 1973-04-04 ARGINIA PIROGLUTAMATE AND PROCEED TO PREPARE IT

Publications (1)

Publication Number Publication Date
AR203747A1 true AR203747A1 (en) 1975-10-15

Family

ID=11270040

Family Applications (1)

Application Number Title Priority Date Filing Date
AR253103A AR203747A1 (en) 1973-04-04 1974-04-02 PROCEDURE TO OBTAIN ARGININE PYROGLUTAMATE

Country Status (9)

Country Link
JP (1) JPS5221572B2 (en)
AR (1) AR203747A1 (en)
CH (1) CH592058A5 (en)
DE (1) DE2416339C3 (en)
ES (1) ES424931A1 (en)
FR (1) FR2224154B1 (en)
GB (1) GB1421089A (en)
IT (1) IT1019020B (en)
ZA (1) ZA742095B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102268U (en) * 1976-01-30 1977-08-03
IT1150694B (en) * 1982-03-18 1986-12-17 Baldacci Lab Spa PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY ACTIVITY
JPS63143376U (en) * 1987-03-10 1988-09-21
IT1244548B (en) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa 5-OXO-L-PROLIN DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATIONS
DE19520792A1 (en) * 1995-06-07 1996-12-12 Bloch Wilhelm Dr Use of nitric oxide synthase inhibitors to inhibit nasal swelling

Also Published As

Publication number Publication date
ES424931A1 (en) 1976-05-16
FR2224154A1 (en) 1974-10-31
GB1421089A (en) 1976-01-14
IT1019020B (en) 1977-11-10
JPS5221572B2 (en) 1977-06-11
DE2416339B2 (en) 1979-02-08
DE2416339A1 (en) 1975-02-13
JPS5035317A (en) 1975-04-04
ZA742095B (en) 1975-04-30
DE2416339C3 (en) 1979-09-27
FR2224154B1 (en) 1977-11-04
CH592058A5 (en) 1977-10-14

Similar Documents

Publication Publication Date Title
AR202297A1 (en) PROCEDURE TO PREPARE PENICILLIN
BR7407915A (en) PERFECTED APPLIANCE TO PREPARE YOGURT
AR202939A1 (en) PROCEDURE TO PRODUCE FORTIMYCIN A
AR203756A1 (en) PROCEDURE TO PREPARE NEW CHALCONA ETHERS
AR211871A1 (en) PROCEDURE TO OBTAIN 7BETA-AMINO-3-CEFEM-3-OL-4-CARBOXYL DERIVATIVES
AR208511A1 (en) (SULFAMOIL-5-PHENYL) -2-AZA 8-PURINONES-6 PREPARATION PROCEDURE
AR207116A1 (en) PROCEDURE TO PREPARE NEW DOTRIACONTAPEPTIDOAMIDES
AR200521A1 (en) PROCEDURE TO PRODUCE 6-DEOXYTETRACYCLINES
AR205275A1 (en) PROCEDURE TO OBTAIN NEW ACIDS 7 - (3ALPHA - (3 - HYDROXY - 3 - AQUYL - 1 PROPENYL -) - 4 - HYDROXY - TETRAHYDRO - 2BETA - THENYL) HEPTANICS OR -5 - HEPTENICS
AR202917A1 (en) SUITABLE SUBSTITUTE TRIAZINYLAMINE STYLBENE COMPOUNDS AS OPTICAL BRIGHTERS AND PROCEDURE TO OBTAIN THEM
AR200781A1 (en) PROCESS TO PREPARE L-LYSINE
IT1003411B (en) BRANCHED PERFLUOROALKANS
AR207459A1 (en) PROCEDURE TO PREPARE PYRIMIDINOQUINOLINS
AR202306A1 (en) PROCEDURE TO PREPARE TRIACETONAMINE
AR203747A1 (en) PROCEDURE TO OBTAIN ARGININE PYROGLUTAMATE
AR200736A1 (en) PROCEDURE TO PRODUCE NEW PIPERACINYL QUINAZOLINADIONES COMPOUNDS
SE400563B (en) OLIGOKARBOXI-ALKANE-PHOSPHONIC ACIDS
AR201709A1 (en) PROCESS TO PREPARE 3-HALOCEPHALOSPORINS
SE401870B (en) POLARIZER
AR202305A1 (en) PROCEDURE TO PREPARE TRIACETONAMINE
AR208337A1 (en) PROCEDURE TO PREPARE 2-HYDROXIMETHYL-3-HYDROXY-6- (1-HYDROXY-2-T-BUTYLAMINE ETHYL) PYRIDINE
AR212586A1 (en) PROCEDURE TO OBTAIN 9-AMINO-9,10-DEHYDRO-9,10-METHANANTRACENE DERIVATIVES
AR201763A1 (en) PROCEDURE TO PREPARE POLIFORMALS
AR204526A1 (en) PROCEDURE TO PREPARE NEW 2-AMINOINDANE DERIVATIVES
AR202319A1 (en) NEW PROCEDURE TO PREPARE 2-ALCOXI-5-SUBSTITUTED SULFAMOYLBENZOIC ACIDS